Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?
<p>Abstract</p> <p>Background</p> <p>Aluminium-containing phosphate binders have long been used for treatment of hyperphosphatemia in dialysis patients. Their safety became controversial in the early 1980's after reports of aluminium related neurological and bone d...
Main Authors: | van Eps Carolyn L, Isbel Nicole M, Campbell Scott B, Hawley Carmel M, Johnson David W, Mudge David W, Petrie James JB |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | BMC Nephrology |
Online Access: | http://www.biomedcentral.com/1471-2369/12/20 |
Similar Items
-
Aluminium phosphate for use as a binder
by: Mulcahy, Cara Louise
Published: (2004) -
Do oral aluminium phosphate binders cause accumulation of aluminium to toxic levels?
by: Roberts Norman B, et al.
Published: (2011-10-01) -
Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients
by: Mudge David W, et al.
Published: (2009-06-01) -
Probable tacrolimus toxicity from tibolone co-administration in a woman: a case report
by: Clark Carolyn J, et al.
Published: (2010-08-01) -
Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report
by: Keasberry Justin, et al.
Published: (2013-01-01)